KR900004877B1 - Process for preparing of 1-carbaphenem -2-m-3-carboxyacid derivatives - Google Patents
Process for preparing of 1-carbaphenem -2-m-3-carboxyacid derivatives Download PDFInfo
- Publication number
- KR900004877B1 KR900004877B1 KR1019880006075A KR880006075A KR900004877B1 KR 900004877 B1 KR900004877 B1 KR 900004877B1 KR 1019880006075 A KR1019880006075 A KR 1019880006075A KR 880006075 A KR880006075 A KR 880006075A KR 900004877 B1 KR900004877 B1 KR 900004877B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- general formula
- compound
- reaction
- added
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 7
- -1 phenylacetyl Chemical group 0.000 claims abstract description 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 5
- 125000003884 phenylalkyl group Chemical group 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- WKDDRNSBRWANNC-ATRFCDNQSA-N Thienamycin Chemical compound C1C(SCCN)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 WKDDRNSBRWANNC-ATRFCDNQSA-N 0.000 description 5
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 238000002329 infrared spectrum Methods 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 3
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- HVRMNEPIBIGCNZ-UHFFFAOYSA-N (4-nitrophenyl)methyl 2-oxoacetate Chemical compound [O-][N+](=O)C1=CC=C(COC(=O)C=O)C=C1 HVRMNEPIBIGCNZ-UHFFFAOYSA-N 0.000 description 1
- MHSGOABISYIYKP-UHFFFAOYSA-N (4-nitrophenyl)methyl carbonochloridate Chemical compound [O-][N+](=O)C1=CC=C(COC(Cl)=O)C=C1 MHSGOABISYIYKP-UHFFFAOYSA-N 0.000 description 1
- XIVUBGOYMBSEMA-UHFFFAOYSA-N 1,4-dioxane;methylsulfinylmethane Chemical compound CS(C)=O.C1COCCO1 XIVUBGOYMBSEMA-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N Glyoxylic acid Natural products OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 238000007239 Wittig reaction Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- KWYZNESIGBQHJK-UHFFFAOYSA-N chloro-dimethyl-phenylsilane Chemical compound C[Si](C)(Cl)C1=CC=CC=C1 KWYZNESIGBQHJK-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 150000003003 phosphines Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- WTUJMUAZXUEIEM-UHFFFAOYSA-N propan-2-yl methanimidate Chemical compound CC(C)OC=N WTUJMUAZXUEIEM-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- OKAFFHNXRJQQET-UHFFFAOYSA-N tert-butylazanium;fluoride;trihydrate Chemical compound O.O.O.[F-].CC(C)(C)[NH3+] OKAFFHNXRJQQET-UHFFFAOYSA-N 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
본 발명은 세균감염증의 치료에 이용치는 다음 구조식(Ⅰ)의 1-카르바페냄-2-엠-3-카복실산, 모노하이드레이트의 신규 공업적 제조방법에 관한 것이다.The present invention relates to a novel industrial method for preparing 1-carbaphenin-2-m-3-carboxylic acid, monohydrate of the following structural formula (I) for use in the treatment of bacterial infections.
본 발명에 의한 신규 제조방법에 의하여 제조되는 상기 일반식(Ⅰ)의 화합물은 광범위한 항균작용과 강력한 활성을 가지며, 베타락탐 항생제의 내성균에 의해서 분비되는 베타락탐 분해효소에도 안정한 항균물질로써 미국특허 제4,194,047호, 제4,292,436호, 제4,374,772호에 의하여 제조될 수 있는 공지의 화합물이다. 그러나 이들 공지의 방법에 따리 일반식(Ⅰ)의 화합물을 제조할 경우The compound of formula (I) prepared by the novel production method according to the present invention has a wide range of antibacterial action and potent activity, and is stable as an antibacterial substance to beta lactam degrading enzyme secreted by resistant bacteria of beta lactam antibiotics. Known compounds that can be prepared by 4,194,047, 4,292,436, 4,374,772. However, when the compound of the general formula (I) is prepared according to these known methods
첫째, 미국특허 제4,194,047호와 제4,374,772호에 의한 제조방법은 티에나마이신을 출발물질로 하는 제조방법으로서 반응온도와 반응용액의 pH에 대한 티에나마이신 자체의 불안정성으로 인하여 반응공정이 복잡할 뿐만 아니라 출발물질인 티에나마이신의 제조에 있어서도 발효법에 의하므로 발효법의 문제점인 시설투자비, 균주의 확보 및 보존 등의 문제와 티에나마이신 자체의 불안정성으로 인하여 발효에 의해 제조된 티에나마이신을 합성에 적당할 정도의 고농도로 농축할 수 없는 등 비경제적인 단점이 있으며, 둘째, 미국특허 제4,292,436호에 의한 방법도 출발물질을 제조하기 위한 반응공정이 복잡하고 이들 출발물질을 제조하기 위해서는 고가의 시약을 이용해야 할뿐 아니라 이들 출발물질을 이용한 일반식(Ⅰ)의 제조는 실제적으로 반응수율이 낮고 반응조작이 복잡한 단점이 있다.First, the preparation method according to US Pat. Nos. 4,194,047 and 4,374,772 is a manufacturing method using thienamycin as a starting material, and the reaction process is complicated due to the instability of thienamycin itself with respect to the reaction temperature and the pH of the reaction solution. In addition, in the production of the starting material thienamycin, the fermentation method is used, and thus, due to problems such as facility investment costs, securing and preservation of strains, and instability of thienamycin itself, the synthesis of thienamycin produced by the fermentation is performed in the synthesis. There is an uneconomical disadvantage, such as not being able to concentrate to a moderately high concentration. Second, the method according to US Pat. No. 4,292,436 also has a complicated reaction process for preparing starting materials, and expensive reagents are needed to prepare these starting materials. In addition to the use of these compounds, the preparation of general formula (I) using these starting materials has a very low reaction yield. The reaction operation is complicated drawbacks.
따라서 본 발명에 의한 일반식(Ⅰ)의 신규 제조방법은 이러한 상기 공지방법의 단점을 보완시킨 방법이며 또한 안정한 상태에서 반응이 진행되고 비교적 고수율로 목적화합물을 얻을 수 있는 방법이다.Therefore, the novel preparation method of the general formula (I) according to the present invention is a method to compensate for the disadvantages of the above known method, and is also a method in which the reaction proceeds in a stable state and a target compound can be obtained in a relatively high yield.
본 발명은 일반식(Ⅲ)의 화합물과 그의 제조방법 및 이를 이용하여 일반식(Ⅰ)의 목적화합물을 제조하는 것을 특징으로 하는 신규의 산업적 제조방법이다.The present invention is a novel industrial production method characterized by preparing a compound of the general formula (III), a method for producing the same, and a target compound of the general formula (I) using the same.
여기서 R1=탄소수 1~6개의 알킬, 페닐 또는 탄소수 7∼12의 페닐알킬, R2=P-니트로벤질옥시카보닐, 페닐아세틸, 페녹시아세틸, 트리메틸실릴Wherein R 1 = alkyl of 1 to 6 carbon atoms, phenyl or phenylalkyl of 7 to 12 carbon atoms, R 2 = P-nitrobenzyloxycarbonyl, phenylacetyl, phenoxyacetyl, trimethylsilyl
여기서 일반식(Ⅲ)의 화합물은 일반식(Ⅷ)과 일반식(Ⅸ)의 화합물을 무수의 유기용매에서 저온에서 반응시킨 후 염기존재 하에서 실릴화제를 가함으로써 제조될 수 있다.The compound of formula (III) may be prepared by reacting a compound of formula (III) with a compound of formula (III) at low temperature in anhydrous organic solvent and then adding a silylating agent in the presence of a base.
여기서, R1, R2는 상기에서 정의한 바와 같다.Here, R 1 , R 2 are as defined above.
상기에서 이용되는 무수의 유기용매로는 반응과정 중에서 부산물로 생성되는 산을 제거할 수 있는 트리에칠아민과 같은 용매가 적당하며 일반식(Ⅸ)의 화합물에 대하여 최소한 2배몰 이상을 가해주는 것이 바람직하다.As the anhydrous organic solvent used in the above, a solvent such as triethylamine capable of removing an acid generated as a by-product during the reaction is suitable, and at least 2 moles of the compound of the general formula is added. desirable.
상기 반응중에 이용되는 염기는 강한 염기를 이용하는 것이 효과적이며 바람직하게는 n-부틸리튬, 페닐리튬 등이 이용될 수 있다. 또한 이때 가해주는 실릴화제로써는 일반식(Ⅸ)을 기준으로 1∼2몰을 가해주는 것이 적당하며 이용되는 실릴화제로는 트리메틸실릴클로라이드, T-부틸디메틸실릴클로라이드, 디메틸페닐실릴클로라이드 등이다.As the base used during the reaction, it is effective to use a strong base, and preferably n-butyllithium, phenyllithium or the like may be used. In this case, as the silylating agent to be added, it is suitable to add 1 to 2 mol based on the general formula (Ⅸ), and the silylating agent used is trimethylsilyl chloride, T-butyldimethylsilyl chloride, dimethylphenylsilyl chloride, and the like.
상기 반응 중에서 일반식(Ⅷ)은 공지의 화합물로써 케텐 발생장치를 이용하여 발생시킬 수 있는 가스상태의 화합물이며 상기 반응 중에서 일반식(Ⅷ)의 화합물은 일반식(Ⅸ)화합물의 1∼2배몰을 가해주는 것이 적당하다.In the reaction, the general formula (VII) is a known compound, which is a gaseous compound that can be generated using a ketene generator, and in the reaction, the compound of the general formula (1) is 1 to 2 times mole of the general formula (IX) It is appropriate to apply.
본 발명에 의한 일반식(Ⅰ)화합물의 제조방법을 살펴보면 일반식(Ⅱ)과 일반식(Ⅲ)을 반응시켜 일반식(Ⅳ)의 화합물을 제조한 후 글리옥실산에스테르를 가하여 일반식(Ⅴ)을 제조한다.Looking at the preparation method of the compound of the general formula (I) according to the present invention to prepare a compound of the general formula (IV) by reacting the general formula (II) and the general formula (III) and then add glyoxylic acid ester ).
다시 포스핀유도체를 가하여 일반식(Ⅵ)의 일라이드를 거쳐 촉매존재 하에 링폐환하여 일반식(Ⅶ)의 카르바페냄을 제조하고 공지의 방법에 의하여 일반식(Ⅰ)의 화합물을 제조하였다.The phosphine derivative was further added to form a carbafein of general formula (VII) by ring closing in the presence of a catalyst via an lide of general formula (VI) to prepare a compound of general formula (I) by a known method.
상기에서 R1과 R2는 앞에서 정의한 바와 같고, R3는 t-부틸디메틸실릴, R4, R5, R6은 각각 저급알킬, 페닐, 메톡시페닐 등이다In the above, R 1 and R 2 are as defined above, R 3 is t-butyldimethylsilyl, R 4 , R 5 , R 6 are lower alkyl, phenyl, methoxyphenyl and the like, respectively.
PNB는 P-니트로 벤질이다.PNB is P-nitro benzyl.
상기 반응과정 중 일반식(Ⅱ)과 일반식(Ⅲ)으로부터 일반식(Ⅳ)을 제조하는 방법은 알카리용액에 일반식(Ⅲ)의 화합물을 녹이고 일반식(Ⅱ)을 포함하는 유기용매를 적가하여 90분 이상 반응을 시킴으로써 제조할 수 있다.Method of preparing general formula (IV) from general formula (II) and general formula (III) during the reaction process is to dissolve the compound of general formula (III) in alkaline solution and dropwise add the organic solvent containing general formula (II) Can be prepared by reacting for 90 minutes or more.
일반식(Ⅳ)에서 일반식(Ⅴ)을 제조하는 반응은 비극성용매에서 반응시키는 것이 바람직하며 이때 이용될 수 있는 용매는 벤젠, 톨루엔 등이며 이때 생성되는 일반식(Ⅴ)은 에틸아세테이트:싸이클로헥산(1:1.5∼1.5:1)의 혼합용매로 크로마토그라피하여 정제하는 것이 바람직하다.In the general formula (IV), the reaction for preparing the general formula (V) is preferably carried out in a nonpolar solvent. The solvents that can be used are benzene, toluene and the like. The general formula (V) produced in this case is ethyl acetate: cyclohexane. It is preferred to purify by chromatography with a mixed solvent of (1: 1.5 to 1.5: 1).
또한 상기 반응에선 일반식(Ⅵ)의 화합물을 제조하는 과정은 일반식(Ⅴ)의 화합물을 무수어프로틱 불활성유기용매 즉, 테트라하이드로퓨란, 디메틸포름아마이드, 디메틸설폭사이드디옥산 등이 이용될 수 있으며 이 반응은 염기 존재 하에서 반응시키는 것이 바람직하며, 이용할 수 있는 적합한 염기로는 2.6-루티딘, 2-피콜린, 피리딘 등이다.In the reaction, the process of preparing the compound of Formula (VI) may be performed using the compound of Formula (V) as anhydrous inert organic solvent, ie, tetrahydrofuran, dimethylformamide, dimethyl sulfoxide dioxane, and the like. It is preferred that the reaction is carried out in the presence of a base, and suitable bases which can be used are 2.6-lutidine, 2-picoline, pyridine and the like.
일반식(Ⅶ)화합물의 제조는 상기 반응과정 중 생성된 일반식(Ⅵ)의 화합물을 정제치 아니하고 직접 분자 내 wittig반응을 이용한 링폐환에 의하여 제조하였으며, 이 반응은 불활성 유기용매 내에서 90∼100℃로 반응시키며 적당한 불활성 용매로는 톨루엔, 벤젠 등이다.The general formula (VII) was prepared by a ring closure ring using a direct intramolecular wittig reaction without purification of the compound of general formula (VI) produced during the reaction. Reaction at 100 ° C and suitable inert solvents are toluene, benzene and the like.
일반식(Ⅶ)에서 일반식(Ⅰ)을 제조하는 방법은 먼저 강한 탈보호시약에 의하여 R3을 제거한 후 수소압력하에서 플라티늄옥사이드 촉매로 가수소분해하여 2번 위치의 R2기와 3번 위치의 P-니트로벤질을 제거하고 공지방법에 의하여 일반식(Ⅰ)의 화합물을 제조하였다.Formula (Ⅶ) in the general formula (Ⅰ) a method for producing the first, after removing the R 3 by the strong deprotection reagent by hydrogenolysis of platinum oxide catalyst under a hydrogen pressure at position 2 R 2 group and the 3-position P-nitrobenzyl was removed and a compound of formula (I) was prepared by a known method.
본 발명의 신규 제조방법에 의한 일반식(Ⅰ)의 화합물의 제조는 다음 실시예에서 보다 상세히 설명하여 이들 실시예로 본 발명이 제한되는 것은 아니다.The preparation of the compound of general formula (I) by the novel preparation method of the present invention will be described in more detail in the following examples, and the present invention is not limited to these examples.
[실시예 1]Example 1
N-(N-P-니트로벤질옥시카보닐)-포름이미도일-2-아미노에탄티올의 제조Preparation of N- (N-P-nitrobenzyloxycarbonyl) -formimidoyl-2-aminoethanethiol
2-아미노에탄티올 14.1g을 186ml의 아세토니트릴에 녹인 후 0℃에서 질소압력하에 디이소프로필 36.7g의 소량씩 가하고 트리메틸실릴클로라이드 17.5g을 가한 12.4ml의 아세토니트릴 용액을 2분에 걸쳐 적가한 후 반응혼합물의 온도를 15분에 걸쳐 서서히 실온으로 올려준 후 다시 0℃로 냉각시켜 용액 A를 제조한다.After dissolving 14.1 g of 2-aminoethanethiol in 186 ml of acetonitrile, 36.7 g of diisopropyl was added in small portions under nitrogen pressure at 0 ° C., and 12.4 ml of acetonitrile added with 17.5 g of trimethylsilyl chloride was added dropwise over 2 minutes. After slowly raising the temperature of the reaction mixture to room temperature over 15 minutes, and cooled to 0 ℃ again to prepare a solution A.
아세토니트릴 124ml에 염산이소프로필 포름이미데이트 8.8g을 녹인 후 0℃ 질소압력하에서 디이소프로필에틸아민 18.6g을 가한 용액에 15.2g의 P-니트로벤질클로로포메이트를 가한 아세토니트릴을 0℃로 유지하며 적가하여 용액 B를 제조한다.After dissolving 8.8 g of isopropyl formimidate in 124 ml of acetonitrile, 18.6 g of diisopropylethylamine was added to a solution of 15.2 g of P-nitrobenzylchloroformate at 0 ° C. under nitrogen pressure, and the acetonitrile was maintained at 0 ° C. And dropwise to prepare Solution B.
용액 B에 준비된 용액 A의 반을 적가하고 반응혼합물을 실온에서 10분간 교반한 후 물 25ml를 가한다.Half of the prepared solution A was added dropwise to the solution B, and the reaction mixture was stirred at room temperature for 10 minutes and 25 ml of water was added thereto.
진공 농축한 잔유물을 디클로로메탄 248ml로 용해하고 물 250ml로 3회씩 세척한다.The vacuum residue was dissolved in 248 ml of dichloromethane and washed three times with 250 ml of water.
디클로로메탄 유기층을 무수황산나트륨으로 건조한 후 진공농축하면 조 상기의 표제화합물이 생성되며 이를 컬럼크로마토그라피에서 에틸아세테이트로 용출시킨 후 감압 농축하면 상기의 표제화합물 14g을 얻는다(수율:79.6%).The dichloromethane organic layer was dried over anhydrous sodium sulfate, and then concentrated in vacuo to give the title compound. Elution with ethyl acetate in column chromatography followed by concentration under reduced pressure yielded 14 g of the title compound (yield: 79.6%).
[실시예 2]Example 2
2-트리메틸실릴옥시-20[N-(N-P-니트로벤질옥시카르보닐)-포름이미도일-2-아미노]에탄티오-에텐의 제조Preparation of 2-trimethylsilyloxy-20 [N- (N-P-nitrobenzyloxycarbonyl) -formimidoyl-2-amino] ethanethio-ethene
실시예 1에서 제조한 표제화합물 14g을 n-부틸리튬 30ml(1.6M in Hexane)가 들어있는 200ml의 트리에틸아민에 가한 후 케텐발생기에 20ml의 아세톤을 가하여 생성되는 케텐가스와 0℃ 이하에서 서서히 반응시킨다.14 g of the title compound prepared in Example 1 was added to 200 ml of triethylamine containing 30 ml of n-butyllithium (1.6 M in Hexane), followed by the addition of 20 ml of acetone to a ketene generator. React.
케텐발생기의 아세톤의 양이 반 이하로 줄어들면 반응을 중단하고 계속하여 0℃를 유지하면서 7.5ml의 트리메틸실릴클로라이드를 가하고 1∼2시간 동안 반응 후 여과한 여액을 감압 농축하면 상기의 표제화합물 15.17g을 얻는다(수율:78%).When the amount of acetone in the ketene generator is reduced to less than half, the reaction is stopped and 7.5 ml of trimethylsilyl chloride is added while maintaining the temperature at 0 ° C., and the filtered filtrate is concentrated under reduced pressure for 1 to 2 hours. g is obtained (yield: 78%).
적외선스펙트럼/KBr/3350cm-1, 1230cm-1, 1110cm-1, 1650cm-1 IR spectrum / KBr / 3350cm -1, 1230cm -1 , 1110cm -1, 1650cm -1
원소분석Elemental analysis
계산치:C; 48.36, H; 5.79, N; 20.58Calculated: C; 48.36, H; 5.79, N; 20.58
이론치:C; 48.55, H; 5.80, N; 10.40Theoretical: C; 48.55, H; 5.80, N; 10.40
[실시예 3]Example 3
(3S,4R)-3-[(1R)-(t-부틸디메틸실릴옥시)에틸-4-2-옥소-2-(N-(N-P-니트로벤질옥시카르보닐)-포름이미도일-2-아미노)에탄티오)에틸]-2-아제티디논의 제조(3S, 4R) -3-[(1R)-(t-butyldimethylsilyloxy) ethyl-4-2-oxo-2- (N- (NP-nitrobenzyloxycarbonyl) -formimidoyl-2- Preparation of Amino) ethanethio) ethyl] -2-azetidinone
실시예 2에서 제조한 표제화합물 15.17g을 55ml의 1N 수산화나트륨 용액에 녹인 후 빙욕에서 20분간 교반하고 11g의 아제티디논을 포함하는 370ml의 디옥산을 적가하여 90분 이상 반응시킨다. 반응용액을 디클로로메탄으로 추출하고 유기층을 물로 세척한 후 무수황산마그네슘으로 건조하여 감압 농축하면 14.6g의 상기 표제화합물을 얻는다(수율:73%).15.17 g of the title compound prepared in Example 2 was dissolved in 55 ml of 1N sodium hydroxide solution, stirred in an ice bath for 20 minutes, and reacted for at least 90 minutes by dropwise addition of 370 ml of dioxane containing 11 g of azetidinone. The reaction solution was extracted with dichloromethane, the organic layer was washed with water, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 14.6 g of the title compound (yield: 73%).
적외선스펙트럼/KBr/3400cm-1, 1770cm-1, 1730cm-1 Infrared Spectrum / KBr / 3400cm -1 , 1770cm -1 , 1730cm -1
원소분석Elemental analysis
계산치:C; 52.17, H; 6.52, N; 10.14Calculated: C; 52.17, H; 6.52, N; 10.14
실측치:C; 52.30, H; 6.43, N; 10.25Found: C; 52.30, H; 6.43, N; 10.25
mp:136∼140℃mp: 136-140 degreeC
[실시예 4]Example 4
P-니트로벤질-2-((3S,4R)-3-(11R)-(t-부탄디메틸실릴옥시)에틸)-4-(2-옥소-2-(N-(N-P-니트로벤질옥시카르보닐)-포름이미도일-2-아미노)에탄티오)에틸-2-옥소아제티딘-1-일)-2-하이드록시아세테이트의 제조P-nitrobenzyl-2-((3S, 4R) -3- (11R)-(t-butanedimethylsilyloxy) ethyl) -4- (2-oxo-2- (N- (NP-nitrobenzyloxycar Preparation of carbonyl) -formimidoyl-2-amino) ethanethio) ethyl-2-oxoazetidin-1-yl) -2-hydroxyacetate
12.9g의 P-니트로벤질글리옥실레이트를 1.1l의 벤젠에 가한 후 14.6g의 실시예 3에서 제조한 표제화합물을 가하여 2시간 동안 가열 환류시킨 후 감압 농축한 잔사를 싸이클로헥산:에틸아세테이트(1:1) 혼합용매로 컬럼크로마토그라피하여 상기의 표제화합물 15.5g을 얻는다(수율:83%).12.9 g of P-nitrobenzylglyoxylate was added to 1.1 l of benzene, and then 14.6 g of the title compound prepared in Example 3 was added thereto, heated to reflux for 2 hours, and then the residue concentrated under reduced pressure was cyclohexane: ethyl acetate (1). : 1) Column chromatography with a mixed solvent gave 15.5 g of the title compound (yield: 83%).
적외선스펙트럼/KBr/3400cm-1, 1780cm-1, 1760cm-1, 1710cm-1, 1604cm-1 Infrared Spectrum / KBr / 3400cm -1 , 1780cm -1 , 1760cm -1 , 1710cm -1 , 1604cm -1
원소분석Elemental analysis
계산치:C; 52.04, H; 5.65, N; 9.20Calculated: C; 52.04, H; 5.65, N; 9.20
실측치:C; 52.12, H; 5.69, N; 9.28Found: C; 52.12, H; 5.69, N; 9.28
[실시예 5]Example 5
P-니트로벤질(5R,6S)-6-((1R)-(t-부틸디메틸실릴옥시)에틸-2-((N-(N-P-니트로벤질옥시카르보닐)-포름이미도일-2-아미노)-에탄티오-2-카르바페냄-3-카르복실레이트의 제조P-nitrobenzyl (5R, 6S) -6-((1R)-(t-butyldimethylsilyloxy) ethyl-2-((N- (NP-nitrobenzyloxycarbonyl) -formimidoyl-2-amino Preparation of) -ethanethio-2-carbafene-3-carboxylate
실시예 4에서 제조한 표제화합물 15.5g을 270ml의 테트라하이드로퓨란에 용해시킨 후 10ml의 2,6-루티딘을 가하고 -30∼-10℃에서 11ml의 티오닐클로라이드를 가한다.After dissolving 15.5 g of the title compound prepared in Example 4 in 270 ml of tetrahydrofuran, 10 ml of 2,6-lutidine is added and 11 ml of thionyl chloride is added at -30 to -10 ° C.
1시간 교반 후 여과한 여액을 감압 농축하고 상기의 고체를 360ml의 디옥산에 녹이고 7.97g의 트리페닐포스핀과 5ml의 2,6-루티딘을 가하여 50~60℃로 가온하고 20시간 교반 후 실온으로 냉각한다. 에틸아세테이트를 적당량 가하고 유기층은 5%의 염산으로 세척하고 무수황산마그네슘으로 건조한다. 감압 농축하여 생성된 잔유물을 톨루엔 2.0l에 녹이고 소량의 하이드로퀴논을 가한다.After stirring for 1 hour, the filtrate was concentrated under reduced pressure, and the solid was dissolved in 360 ml of dioxane, 7.97 g of triphenylphosphine and 5 ml of 2,6-lutidine were added thereto, warmed to 50-60 ° C., and stirred for 20 hours. Cool to room temperature. An appropriate amount of ethyl acetate is added and the organic layer is washed with 5% hydrochloric acid and dried over anhydrous magnesium sulfate. The residue obtained by concentration under reduced pressure was dissolved in 2.0 l of toluene and a small amount of hydroquinone was added.
혼합물을 90∼100℃에서 20시간 가량 교반하고 냉각한다. 용매를 감압하에서 제거하고 잔유물은 싸이클로헥산:에틸아세테이트(2:1) 혼합용매로 크로마토그라피하여 상기의 표제화합물 6.8g을 얻는다(수율:46%).The mixture is stirred at 90-100 ° C. for about 20 hours and cooled. The solvent is removed under reduced pressure and the residue is chromatographed with a cyclohexane: ethyl acetate (2: 1) mixed solvent to give 6.8 g of the title compound (yield: 46%).
적외선스펙트럼/KBr/1800cm-1, 1700cm-1, 1610cm-1, 1580cm-1 Infrared Spectrum / KBr / 1800cm -1 , 1700cm -1 , 1610cm -1 , 1580cm -1
[실시예 6]Example 6
P-니트로벤질(5R,6S)-6-((1R)-하이드록시에틸)-2-((N-P-니트로벤질옥시카르보닐)-포름아미도일-2-아미노)-에탄티오-2-카르바페넴-3-카르복실레이트의 제조P-nitrobenzyl (5R, 6S) -6-((1R) -hydroxyethyl) -2-((NP-nitrobenzyloxycarbonyl) -formamidoyl-2-amino) -ethanethio-2- Preparation of Carbapenem-3-carboxylate
실시예 5에서 제조한 표제화합물 5.2g을 테트라하이드로퓨란 260ml에 녹인 후 초산 3.9ml, 테트라 t-부틸암모늄플루오라이드 삼수화물 11.5g을 빙욕에서 반응시킨다.After dissolving 5.2 g of the title compound prepared in Example 5 in 260 ml of tetrahydrofuran, 3.9 ml of acetic acid and 11.5 g of tetra t-butylammonium fluoride trihydrate were reacted in an ice bath.
반응혼합물을 실온에서 가온하고 15~20시간 동안 교반한다. 에틸아세테이트를 반응혼합물에 가하고 유기층은 물로 세척한 후 무수황산마그네슘으로 건조한다.The reaction mixture is warmed at room temperature and stirred for 15-20 hours. Ethyl acetate is added to the reaction mixture, and the organic layer is washed with water and dried over anhydrous magnesium sulfate.
용매를 감압하에서 제거하고 잔유물을 싸이클로헥산:에틸아세테이트(1:2) 혼합용매로 크로마토그라피시켜 상기의 표제화합물 4.15g을 얻는다(수율:95%).The solvent was removed under reduced pressure and the residue was chromatographed with a cyclohexane: ethyl acetate (1: 2) mixed solvent to give 4.15 g of the title compound (yield: 95%).
원소분석Elemental analysis
계산치:C; 52.94, H; 4.25, N; 11.44Calculated: C; 52.94, H; 4.25, N; 11.44
실측치:C; 52.81, H; 4.34, N; 11.55Found: C; 52.81, H; 4.34, N; 11.55
핵자기 공명Nuclear magnetic resonance
1.23(S, CH3), 3.4(m, SCH2), 3.36(d ofd, 6H), 3.58(4, -CH2), 3.7(m, NH2), 4.14(m, 8-H), 4.34(m, 5-H), 5.3(S, -OCH2), 8.62(bs, N=CH-)1.23 (S, CH 3 ), 3.4 (m, SCH 2 ), 3.36 (d of d, 6H), 3.58 (4, -CH 2 ), 3.7 (m, NH 2 ), 4.14 (m, 8-H), 4.34 (m, 5-H), 5.3 (S, -OCH 2 ), 8.62 (bs, N = CH-)
mp:148~151℃mp: 148-151 degreeC
[실시예 7]Example 7
(5R,6S)-6-((1R)-하이드록시에틸)-2-((N-포름이미도일)-2-아미노)에탄티오-2-카르바페넴-3-카르복실산의 제조Preparation of (5R, 6S) -6-((1R) -hydroxyethyl) -2-((N-formimidoyl) -2-amino) ethanethio-2-carbapenem-3-carboxylic acid
실시예 6의 생성물 4g을 테트라하이드로퓨란 400ml와 0.5M 모노폴리노프로판설포닌산(수산화나트륨을 가하여 pH7.0으로 조절)과 물 400ml를 40psi의 수소압력하에서 45분여 동안 플라티늄옥사이드 촉매 하에 반응시킨다.4 g of the product of Example 6 is reacted with 400 ml of tetrahydrofuran, 0.5 M monopolynopropanesulphonic acid (adjusted to pH 7.0 by addition of sodium hydroxide) and 400 ml of water under a platinum oxide catalyst for 45 minutes under a hydrogen pressure of 40 psi.
촉매는 여과에 의해 제거하고 물로 세척한 후 수용층을 감압하에서 농축한다.The catalyst is removed by filtration, washed with water and the aqueous layer is concentrated under reduced pressure.
농축용액을 크로마토그라피시키고 처음에는 물로 이어서 2%외 아세톤, 물로 각각 용출시켜 상기의 표제화합물 1.11g을 얻는다(수율:59%).The concentrated solution was chromatographed and eluted first with water followed by acetone and water in addition to 2% to give 1.11 g of the title compound (yield: 59%).
[실시예 8]Example 8
N-포름이미도일티에나마이신모노하이드레이트의 제조Preparation of N-formimidoylthienamycin monohydrate
실시예 7의 표제화합물 1.11g을 물 18ml와 95%에탄올 100ml의 혼합용액에 용해한 후 빙욕에서 15시간 동안 교반한다. 이어 결징씨드를 가하고 결정이 생성되면 원심 분리하여 상등액을 제거하고 에탄올로 세척하고 50℃의 진공상태에서 건조하면 상기의 표제화합물 1g을 얻는다(수율:90%).1.11 g of the title compound of Example 7 was dissolved in a mixed solution of 18 ml of water and 100 ml of 95% ethanol and stirred for 15 hours in an ice bath. Then, the seeding seed was added and crystals were formed. The supernatant was removed by centrifugation, washed with ethanol, and dried under vacuum at 50 ° C. to obtain 1 g of the title compound (yield: 90%).
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019880006075A KR900004877B1 (en) | 1988-05-24 | 1988-05-24 | Process for preparing of 1-carbaphenem -2-m-3-carboxyacid derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019880006075A KR900004877B1 (en) | 1988-05-24 | 1988-05-24 | Process for preparing of 1-carbaphenem -2-m-3-carboxyacid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890017232A KR890017232A (en) | 1989-12-15 |
KR900004877B1 true KR900004877B1 (en) | 1990-07-09 |
Family
ID=19274616
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880006075A KR900004877B1 (en) | 1988-05-24 | 1988-05-24 | Process for preparing of 1-carbaphenem -2-m-3-carboxyacid derivatives |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR900004877B1 (en) |
-
1988
- 1988-05-24 KR KR1019880006075A patent/KR900004877B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR890017232A (en) | 1989-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4631150A (en) | Process for the preparation of penems | |
Hanessian et al. | A novel ring-closure strategy for the carbapenems: the total synthesis of (+)-thienamycin | |
CA1234099A (en) | Process for the production of penems | |
US4395418A (en) | Penem-3-carboxylic acid derivatives | |
CA1282415C (en) | Azetidin-2-on derivatives and process for production thereof | |
KR100337053B1 (en) | Thiol compounds | |
US5286721A (en) | 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds | |
KR100377448B1 (en) | Intermediate of Carbapenem Antibiotics and Process for the Preparation thereof | |
HU194892B (en) | Process for producing new peneme derivatives | |
KR900004877B1 (en) | Process for preparing of 1-carbaphenem -2-m-3-carboxyacid derivatives | |
AU661192B2 (en) | 4-substituted alkyl carbapenem antibiotics | |
PL172378B1 (en) | Method of obtaining novel 4-substituted azetidinones | |
EP0209886B1 (en) | Beta-n-substituted aminothiol ester and process for preparing the same | |
KR100298922B1 (en) | Method for preparing 4-substituted azetidinone derivatives | |
JP2696807B2 (en) | Preparation of carbapenem derivatives | |
SE460197B (en) | NEW CARBAPENE MEMBER DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF | |
KR100289512B1 (en) | Method for preparing beta-lactam compound and intermediates thereof | |
US5055463A (en) | Spirocyclic 6-amido carbapenems | |
JP2643753B2 (en) | Method for producing 2-oxycarbapenem derivative | |
US4698339A (en) | Carbapenems, their production and use | |
HU200781B (en) | Process for producing azetidinone-n-(phosphonomethyl)-esters | |
CA1263117A (en) | Carbapenems, their production and use | |
KR100262240B1 (en) | 3-substituted-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylate compounds | |
US5183887A (en) | Spirocyclic 6-amido-carbapenems and azetidinones | |
KR0167718B1 (en) | Ñô-methylcarbepenem derivative and process for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |